Results 81 to 90 of about 7,407 (178)

Studies on immunology of Leishmania mexicana [PDF]

, 2007
Leishmaniasis is a worldwide disease prevalent in many tropical and sub tropical countries. Treatment of Leishmaniasis by chemotherapy is not wholly effective and is usually accompanied by unpleasant side effects. The development of an effective and inexpensive vaccine represents a practical way to control the disease, however at present no safe and ...
openaire  

Leishmania mexicana centrin knockout parasites promote M1-polarizing metabolic changes. [PDF]

iScience, 2023
Volpedo G, Pacheco-Fernandez T, Oljuskin T, Markle HL, Azodi N, Hamano S, Matlashewski G, Gannavaram S, Nakhasi HL, Satoskar AR.   +9 more
europepmc   +1 more source

Clinical picture of cutaneous leishmaniases due to Leishmania (Leishmania) mexicana in the Yucatan peninsula, Mexico

Memorias do Instituto Oswaldo Cruz, 2001
Localized cutaneous leishmaniasis (LCL), known as "chiclero's ulcer" in southeast Mexico, was described by Seidelin in 1912. Since then, the sylvatic region of the Yucatan peninsula has been identified as an endemic focus of LCL.
Andrade-Narváez Fernando J, Vargas-González Alberto, Canto-Lara Silvia B, Damián-Centeno Alma G   +3 more
doaj  

Complex cutaneous infection by Leishmania mexicana treated with miltefosine. [PDF]

JAAD Case Rep, 2022
Sadowsky RL, Emerson CM, Reid DC.
europepmc   +1 more source

Seasonal transmission of Leishmania (Leishmania) mexicana in the state of Campeche, Yucatan Peninsula, Mexico

Memorias do Instituto Oswaldo Cruz, 2003
In the Yucatan Peninsula, Mexico, localized cutaneous leishmaniasis (LCL) caused by Leishmania (Leishmania) mexicana is a typical wild zoonosis restricted to the forest, and humans are only accidentally involved. The transmission of L.
Andrade-Narvaez Fernando J, Lara Silvia B Canto, Van Wynsberghe Nicole R, Rebollar-Tellez Eduardo A, Vargas-Gonzalez Alberto, Albertos-Alpuche Nelly E   +5 more
doaj  

Catalase impairs Leishmania mexicana development and virulence. [PDF]

Virulence, 2021
Sádlová J, Podešvová L, Bečvář T, Bianchi C, Gerasimov ES, Saura A, Glanzová K, Leštinová T, Matveeva NS, Chmelová Ľ, Mlacovská D, Spitzová T, Vojtková B, Volf P, Yurchenko V, Kraeva N.   +15 more
europepmc   +1 more source

Queuosine tRNA modification regulates translational adaptation and virulence of Leishmania mexicana. [PDF]

PLoS Biol
Kumar B, Kovářová J, Boudová M, Kulkarni S, Pacheco Fernandez T, Satoskar A, Paris Z.   +6 more
europepmc   +1 more source

Triose Phosphate Isomerase Structure-Based Virtual Screening and In Vitro Biological Activity of Natural Products as Leishmania mexicana Inhibitors. [PDF]

Pharmaceutics, 2023
González-Morales LD, Moreno-Rodríguez A, Vázquez-Jiménez LK, Delgado-Maldonado T, Juárez-Saldivar A, Ortiz-Pérez E, Paz-Gonzalez AD, Lara-Ramírez EE, Yépez-Mulia L, Meza P, Rivera G.   +10 more
europepmc   +1 more source

Detection of <i>Leishmania mexicana</i> in the broad-tailed bat <i>Nyctinomops laticaudatus</i> (Chiroptera: Molossidae) in southeastern Mexico. [PDF]

Int J Parasitol Parasites Wildl
Chan-González LM, Moguel-Chin WI, Tello-Martín R, MacSwiney González MC, Canché-Pool EB, Hernández-Mena DI, Panti-May JA.   +6 more
europepmc   +1 more source

CXCR5 and TIM-3 expressions define distinct exhausted T cell subsets in experimental cutaneous infection with Leishmania mexicana. [PDF]

Front Immunol, 2023
Diupotex M, Zamora-Chimal J, Gajón JA, Bonifaz LC, Becker I.   +4 more
europepmc   +1 more source